Day: February 27, 2024

3D Systems Reports Fourth Quarter and Full Year 2023 Financial Results (Unaudited)

3D Systems Reports Fourth Quarter and Full Year 2023 Financial Results (Unaudited)

ROCK HILL, S.C., Feb. 27, 2024 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter Financial Results (Unaudited)(All numbers are unaudited and are presented in thousands, except per share amounts or otherwise noted) Q4 2023 revenue of $114,848 decreased 13.5% compared to Q4 2022 due to significant softness in dental orthodontics and depressed printer sales from delayed customer capex investments Q4 2023 gross profit margin of 40.4% and Non-GAAP gross profit margin(1) of 41.9%. Non-GAAP gross profit margin represents an increase from prior year primarily driven by product mix Q4 2023 Net loss of $300,412, diluted loss per share of $2.30, primarily driven by the non-cash impairment of goodwill and other intangible...

Continue reading

Purpose Investments Inc. Announces Final February 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

Purpose Investments Inc. Announces Final February 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today the final February 2024 distribution rates for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund. The following table reflects the final distribution amounts for the month of February. Ex-distribution date is February 28, 2024. Open-End Fund Ticker Symbol Final distribution per unit Record Date Payable Date Distribution Frequency Purpose USD Cash Management Fund – ETF Units MNU.U US $ 0.4398 02/28/2024 03/07/2024 Monthly Purpose Cash Management Fund – ETF Units MNY $ 0.4050 02/28/2024 03/07/2024 Monthly Purpose High Interest Savings Fund – ETF Units PSA $ 0.1947 02/28/2024 03/07/2024 Monthly Purpose US Cash Fund – ETF Units PSU.U US $ 0.4106 02/28/2024 03/07/2024 Monthly About...

Continue reading

Reliq Health Technologies, Inc. Announces Expansion of Mental Health Services

Reliq Health Technologies, Inc. Announces Expansion of Mental Health Services

HAMILTON, Ontario, Feb. 27, 2024 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has expanded its mental health services portfolio and expects to add 10,000 new mental health patients to its platform in 2024. “We are very pleased to be adding cognitive assessments to our portfolio of mental health services,” said Chris Shields, CEO at Reliq Health Technologies, Inc. “Many of our existing and potential clients have requested that Reliq offer additional products and services in the mental healthcare area, particularly for patients in Skilled Nursing and Assisted Living Facilities. Providing cognitive...

Continue reading

Vivid Seats to Report Fourth Quarter and Full Year 2023 Financial Results

Vivid Seats to Report Fourth Quarter and Full Year 2023 Financial Results

CHICAGO, Feb. 27, 2024 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ:SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, will report financial results for the fourth quarter and full year 2023 on Tuesday, March 5, 2024, before the U.S. stock market opens. Management will discuss the results on a webcast at 8:30 a.m. ET. The live webcast and replay can be accessed at https://investors.vividseats.com/. About Vivid Seats Founded in 2001, Vivid Seats is a leading online ticket marketplace committed to becoming the ultimate partner for connecting fans to the live events, artists, and teams they love. Based on the belief that everyone should “Experience It Live,” the Chicago-based company provides...

Continue reading

MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call

MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call

ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter of 2023 after the market closes on Thursday, March 7, 2024. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, March 7, 2024, at 4:30 pm ET. Conference Call Information To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can...

Continue reading

QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery

QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery

QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-driven drug discovery // AI-driven insights complement human-curated QIAGEN Biomedical KB-HD and help identify novel relationships between diseases, biological pathways and molecular interactions that may be missed by traditional methods // Workflow cuts down on hypothesis testing time and speeds up the identification of promising therapeutic avenues with clear, structured data Venlo, the Netherlands, and Redwood City, California, Feb. 27, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel drug discovery in the pharma and biotech industries. This...

Continue reading

Rocky Mountain Chocolate Factory Unveils Tempting Easter Treats and Spring Chocolate Lineup

Rocky Mountain Chocolate Factory Unveils Tempting Easter Treats and Spring Chocolate Lineup

Rocky Mountain Chocolate’s 2024 spring products include exciting new chocolate cream eggs, build-your-own Easter basket treats, and customer-favorite Lemon Bar Toffee DURANGO, Colo., Feb. 27, 2024 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory, Inc. (NASDAQ: RMCF) (“Rocky Mountain Chocolate”, the “Company,” “we” or “RMCF”), is an international franchiser and manufacturer of premium chocolates and other confectionary products with a presence in over 270 locations throughout the United States, has announced that its spring chocolate line-up for 2024 is out and available now. Spring flavors and classic Easter treats return, along with new favorites to brighten the season. Products are available through its retail stores and online for a limited time: 5 Varieties of Filled Chocolate Easter...

Continue reading

Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination

Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination

Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) — EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m. Eastern Time, on Tuesday, March 5, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (“Pubco”), pursuant to a Business Combination Agreement by and among EDOC, American Physicians LLC, a Delaware limited liability company, AOI Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary...

Continue reading

PHX Energy Announces All-Time Record Annual Financial Results

PHX Energy Announces All-Time Record Annual Financial Results

CALGARY, Alberta, Feb. 27, 2024 (GLOBE NEWSWIRE) — Fourth Quarter Highlights For the three-month period ended December 31, 2023, PHX Energy generated consolidated revenue of $165.3 million, the highest level of fourth quarter revenue on record and the third highest level of quarterly revenue in the Corporation’s history. Revenue in the third and first quarter of 2023 are the first and second highest quarterly revenue on record, respectively. Consolidated revenue in the 2023-quarter included $10.3 million of motor rental revenue and $0.9 million of motor equipment and parts sold. Earnings from continuing operations increased by 63 percent to $33.1 million, $0.68 per share, in the 2023-quarter from $20.3 million, $0.39 per share, in the 2022 three-month period. The 2023-quarter’s earnings are the highest level of quarterly earnings...

Continue reading

West Red Lake Gold Announces a US$20 Million Private Placement of Gold Linked Notes

West Red Lake Gold Announces a US$20 Million Private Placement of Gold Linked Notes

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or “WRLG” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF), is pleased to announce that it has entered into an agreement with Raymond James Ltd. to act as sole bookrunner and lead agent, on behalf of a syndicate of agents (together, the “Agents”), in connection with a marketed “best efforts” private placement of units of the Company (each, a “Unit”) at a price of US$1,000 per Unit (the “Offering Price”) for gross proceeds of US$20,000,000 (the “Offering”). The Agents will have the option to sell up to an additional 15% of the Units offered, exercisable, in whole or in part, at any time up to 48 hours prior to the Closing Date (as defined below) to cover over-allotments,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.